Carragelose® products
Currently, seven different common cold products based on Carragelose® are marketed. Furthermore, the launch of an allergen-blocking nasal spray and mositurizing eye drops is plannend for 2024. Carragelose® products are CE-certified (MDD) and protected by a strong patent family.
Marinomed is also developing a decongestant nasal spray combining Carragelose® and Xylometazoline as well as an inhalable formulation of Carragelose® for the treatment of viral infections of the upper and lower respiratory tract.
